TP53 and B-cell chronic lymphocytic leukemia: To delineate cell specific effects, we next investigated whether simultaneous activation of the EP4 receptor by PgE1-OH or L-902688 and targeting of CD20 antigen by MAb leads to an enhanced cytotoxic effect in p53-deficient CLL cells MEC-1.